王凌菲,王生兰,赵得雄

胎儿生长受限（Fetal growth restriction，FGR）是当今产前预测，诊断及监护中最艰巨的挑战之一。其在妊娠期的发病率相对较高，是引起围生儿发病和死亡的重要因素，也是影响儿童远期发育成长的负面因素。本文将从母体因素、胎儿因素、胎盘、脐带和遗传这几个方面综合论述FGR发生的相关影响因素的研究现状。以便对FGR进行早期的识别与诊断，进而加强对发生该疾病的孕妇的妊娠期监护，从而改善妊娠结局，减少不良妊娠结局的发生，促进围生儿和儿童的健康成长。

胎儿生长受限；影响因素；妊娠结局；母体因素；胎儿因素；遗传因素

[1] 段涛,杨慧霞,胡娅莉等.胎儿生长受限专家共识(2019版)[J].中国产前诊断杂志(电子版),2019,11(04):78-98. [2] Martins J G,Biggio J R,Abuhamad A,et al.Society for Maternal-Fetal Medicine Consult Series#52:diagnosis and management of fetal growth restriction:(replaces clinical guideline number 3,April 2012)[J].Am J Obstet Gynecol,2020,223(4):B2-B17. [3] Yu M,Liu Y,Wang L.[Retracted]Analysis of Causes and Results of Fetal Growth in Utero Caused by Genetic Factors Detected by Ultrasound[J].Contrast Media Mol Imaging,2022,2022(1):3703132. [4] Yu X,Yao Y,Wang D,et al.Prediction of Fetal Growth Restriction for Fetal Umbilical Arterial/Venous Blood Flow Index Evaluated by Ultrasonic Doppler under Intelligent Algorithm[J].Comput Math Methods Med,2022,2022(1):7451185. [5] 蒲杰，胎儿生长受限孕妇的识别､监测与转诊[J].中国计划生育和妇产科,2018,10(05):8-13. [6] Leitner Y,Fattal-Valevski A,Geva R,et al.Neurodevelopmental outcome of children with intrauterine growth retardation:a longitudinal,10-year prospective study[J].J Child Neurol,2007,22(5):580-587. [7] Yener G,Kavak S B,Gul Y,et al.Elabela levels in pregnancies with intrauterine growth retardation[J].Ginekol Pol,2023,94(2):113-118. [8] Sun C,Groom K M,Oyston C,et al.The placenta in fetal growth restriction:what is going wrong?[J].Placenta,2020,96:10-18. [9] American College of Obstetricians and Gynecologists.ACOG Practice Bulletin No.204:fetal growth restriction[J].Obstet Gynecol,2019,133(2):e97-e109. [10] Sharma D,Sharma P,Shastri S.Genetic,metabolic and endocrine aspect of intrauterine growth restriction:an update[J].J Matern Fetal Neonatal Med,2017,30(19):2263-2275. [11] Steegers‐Theunissen R P M,Smith S C,Steegers E A P,et al.Folate affects apoptosis in human trophoblastic cells[J].BJOG,2000,107(12):1513-1515. [12] 杨俊娟,郭华峰,柳蕊.VitB12､叶酸､同型半胱氨酸和血管内皮生长因子水平与胎儿生长受限的相关性[J].中国妇幼健康研究,2023,34(06):12-16. [13] 付林,陈远华,于震等.母体孕期维生素D缺乏诱发胎儿生长受限[J].中国药理学通报,2021,37(04):591-592. [14] 王煚楠,徐佳丽,赵艺敏等.维生素D缺乏经Hippo-YAP信号通路抑制胎盘发育诱发胎儿宫内生长受限[J].营养学报,2022,44(03):270-275Neerhof M G.Causes of intrauterine growth restriction[J].Clin Perinatol,1995,22(2):375-385. [15] Neerhof M G.Causes of intrauterine growth restriction[J].Clin Perinatol,1995,22(2):375-385. [16] Auriti C,De Rose D U,Santisi A,et al.Pregnancy and viral infections:Mechanisms of fetal damage,diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus[J].Biochim Biophys Acta Mol Basis Dis,2021,1867(10):166198. [17] 焦立媛,王华,武硕.胎儿生长受限的病因研究进展[J].国际妇产科学杂志,2018,45(01):10-13. [18] 童嘉宁,牛建民.胎儿生长受限的病因学探讨[J].中国实用妇科与产科杂志,2020,36(08):688-692. [19] 陈瑞欣,漆洪波,刘兴会.2021年美国妇产科医师协会胎儿生长受限指南解读[J].实用妇产科杂志,2021,37(12):907-909. [20] Yamamoto R,Ishii K,Nakajima E,et al.Ultrasonographic prediction of antepartum deterioration of growth‐restricted fetuses after late preterm[J].J Obstet Gynaecol Res,2018,44(6):1057-1062. [21] Eydoux P,Choiset A,Le Porrier N,et al.Chromosomal prenatal diagnosis:study of 936 cases of intrauterine abnormalities after ultrasound assessment[J].Prenat Diagn,1989,9(4):255-269. [22] Sickler G K,Nyberg D A,Sohaey R,et al.Polyhydramnios and fetal intrauterine growth restriction:ominous combination[J].J Ultrasound Med,1997,16(9):609-614. [23] Walter A,Calite E,Berg C,et al.Prenatal diagnosis of fetal growth restriction with polyhydramnios,etiology and impact on postnatal outcome[J].Sci Rep,2022,12(1):415. [24] Nardozza L M M,Caetano A C R,Zamarian A C P,et al.Fetal growth restriction:current knowledge[J].Arch Gynecol Obstet,2017,295:1061-1077. [25] 母仕银.胎儿生长受限病因及其变迁特点分析[D].浙江大学,2021. [26] Chen Q,Viall C,Kang Y,et al.Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding:a contribution to the pathogenesis of pre-eclampsia in affected women?[J].Placenta,2009,30(9):767-773. [27] Di Simone N,Castellani R,Caliandro D,et al.Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules[J].Fertil Steril,2002,77(4):805-811. [28] de Groot P G,Urbanus R T.Antiphospholipid syndrome–not a noninflammatory disease[C]//Semin Thromb Hemost.Thieme Medical Publishers,2015:607-614. [29] 文慧.妊娠期糖尿病并发胎儿生长受限的临床分析[J].实用预防医学,2005(03):491-493. [30] 郭雯婷,张燕,王晋.妊娠期糖尿病患者血管内皮功能和氧化应激水平与早发型胎儿生长受限的相关性分析[J].中国医药导刊,2023,25(03):292-296. [31] Ounsted M,Moar V A,Scott A.Risk factors associated with small‐for‐dates and large‐for‐dates infants[J].Br J Obstet Gynaecol,1985,92(3):226-232. [32] 徐蓓,魏莎蔓,靳镭.降低辅助生殖技术中多胎妊娠的对策[J].中国实用妇科与产科杂志,2023,39(10):978-983. [33] Sukhwani M,Antolín E,Herrero B,et al.Management and perinatal outcome of selective intrauterine growth restriction in monochorionic pregnancies[J].J Matern Fetal Neonatal Med,2021,34(23):3838-3843. [34] 赵玉洁,张英.不同绒毛膜性的双胎选择性胎儿生长受限的临床特征及结局比较[J].安徽医科大学学报,2023,58(11):1966-1970. [35] Cai M,Lin N,Su L,et al.Fetal growth restriction:associated genetic etiology and pregnancy outcomes in a tertiary referral center[J].J Transl Med,2022,20(1):168. [36] 谢幸,孔北华,段涛主编;林仲秋,狄文,马丁,曹云霞,漆洪波副主编.妇产科学第9版[M].北京:人民卫生出版社,2018.07. [37] Burton G J,Jauniaux E.Pathophysiology of placental-derived fetal growth restriction[J].Am J Obstet Gynecol,2018,218(2):S745-S761. [38] Nordenvall M,Sandstedt B,Ulmsten U.Relationship between placental shape,cord insertion,lobes and gestational outcome[J].Acta Obstet Gynecol Scand,1988,67(7):611-616. [39] Toal M,Chan C,Fallah S,et al.Usefulness of a placental profile in high-risk pregnancies[J].Am J Obstet Gynecol,2007,196(4):363.e1-363.e7. [40] Kurt Benirschke,Graham J.Burton,Rebecca N Baergen.Pathology of the Human Placenta[M].Springer Berlin Heidelberg.2012. [41] Redline R W.Classification of placental lesions[J].Am J Obstet Gynecol,2015,213(4):S21-S28. [42] Snijders R J M,Sherrod C,Gosden C M,et al.Fetal growth retardation:associated malformations and chromosomal abnormalities[J].Am J Obstet Gynecol,1993,168(2):547-555. [43] Anandakumar C,Chew S,Wong Y C,et al.Early asymmetric IUGR and aneuploidy[J].J Obstet Gynaecol Res,1996,22(4):365-370. [44] Li L,Zhang X,Shi Q,et al.Ultrasonographic findings and prenatal diagnosis of complete trisomy 17p syndrome:A case report and review of the literature[J].J Clin Lab Anal,2021,35(1):e23582. [45] Chen C P,Chen M,Wang L K,et al.Low-level mosaicism for trisomy 16 at amniocentesis in a pregnancy associated with intrauterine growth restriction and a favorable outcome[J].Taiwan J Obstet Gynecol,2021,60(2):345-349. [46] Diderich K E M,Romijn K,Joosten M,et al.The potential diagnostic yield of whole exome sequencing in pregnancies complicated by fetal ultrasound anomalies[J].Acta Obstet Gynecol Scand,2021,100(6):1106-1115. [47] Zhou H,Fu F,Wang Y,et al.[J].Int J Gynaecol Obstet,2023,161(3):1004-1011. [48] Hannan N J,Stock O,Spencer R,et al.Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth[J].BMC Med,2020,18:1-16. [49] Tagliaferri S,Cepparulo P,Vinciguerra A,et al.miR-16-5p,miR-103-3p,and miR-27b-3p as early peripheral biomarkers of fetal growth restriction[J].Front Pediatr,2021,9:611112. [50] Sun P,Zhang K,Hassan S H,et al.Endothelium-targeted deletion of microRNA-15a/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery[J].Circ Res,2020,126(8):1040-1057. [51] Leung L Y,Chan C P Y,Leung Y K,et al.Comparison of miR-124-3p and miR-16 for early diagnosis of hemorrhagic and ischemic stroke[J].Clin Chim Acta,2014,433:139-144. [52] Vinciguerra A,Formisano L,Cerullo P,et al.MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits[J].Mol Ther,2014,22(10):1829-1838. [53] Yuan Y,Zhang Z,Wang Z G,et al.MiRNA-27b regulates angiogenesis by targeting AMPK in mouse ischemic stroke model[J].Neuroscience,2019,398:12-22. [54] MandòC,De Palma C,Stampalija T,et al.Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia[J].Am J Physiol Endocrinol Metab,2014,306(4):E404-E413. [55] Joo E H,Kim Y R,Kim N,et al.Effect of endogenic and exogenic oxidative stress triggers on adverse pregnancy outcomes:Preeclampsia,fetal growth restriction,gestational diabetes mellitus and preterm birth[J].Int J Mol Sci,2021,22(18):10122.

点击下载PDF